European Event-Driven Analyst

Jesus Rodriguez Aguilar

Event-Driven

<ul>
<li>The UK’s CMA cleared the Keysight-Spirent deal without a Phase 2 investigation, removing a major regulatory hurdle for the acquisition's completion.</li>
<li>If the acquisition is not finalized by June 30, 2025, Spirent shareholders will receive an additional 1p per share, compensating for the delay.</li>
<li>With a 7% gross spread and an 89% probability of completion, market confidence in the acquisition remains strong, supported by shareholder approval and regulatory progress.</li>
</ul>


The UK’s CMA cleared the Keysight-Spirent deal without a Phase 2 investigation, removing a major regulatory hurdle for the acquisition's completion.
If the acquisition is not finalized by June 30, 2025, Spirent shareholders will receive an additional 1p per share, compensating for the delay.
With a 7% gross spread and an 89% probability of completion, market confidence in the acquisition remains strong, supported by shareholder approval and regulatory progress.


UK Competition Regulator Clears Keysight/Spirent Deal

Index Rebal Trades & Special Situations, Quiddity Advisors

Janaghan Jeyakumar, CFA

Index Rebal Trades & Special Situations

Quiddity Advisors

Pan-Asia Catalysts/Events

Index Rebalance

<ul>
<li>In this insight, we take a look at the potential index changes for F100 and F250 in the run-up to the December 2025 index rebal event.</li>
<li>We see four M&amp;A-related intra-review changes for the F250 index <em>prior to</em> the December 2025 rebal and then four more after the rebal event.</li>
<li>Our latest estimates suggest there <em>could be</em> no regular changes for the F100 and F250 indices during the December 2025 rebalance.</li>
</ul>


In this insight, we take a look at the potential index changes for F100 and F250 in the run-up to the December 2025 index rebal event.
We see four M&amp;A-related intra-review changes for the F250 index prior to the December 2025 rebal and then four more after the rebal event.
Our latest estimates suggest there could be no regular changes for the F100 and F250 indices during the December 2025 rebalance.


Quiddity Leaderboard F100/F250 Dec25: Solid Lineup of High-Impact Intra-Review Changes

Schroder Asian Total Return In / Index Rebalance

<ul>
<li>In this insight, we take a look at the potential index changes for F100 and F250 in the run-up to the December 2025 index rebal event.</li>
<li>We see five M&amp;A-related intra-review changes for the F250 index prior to the December 2025 rebal and then three more after the rebal event.</li>
<li>Our latest estimates suggest there could be no regular changes for the F100 and F250 indexes during the December 2025 rebalance.</li>
</ul>


In this insight, we take a look at the potential index changes for F100 and F250 in the run-up to the December 2025 index rebal event.
We see five M&amp;A-related intra-review changes for the F250 index prior to the December 2025 rebal and then three more after the rebal event.
Our latest estimates suggest there could be no regular changes for the F100 and F250 indexes during the December 2025 rebalance.


Quiddity Leaderboard F100/F250 Dec25: Intra-Review Changes Galore; High-Impact Replacement Names

<ul>
<li>In this insight, we take a look at the potential index changes for F100 and F250 in the run-up to the September 2025 index rebal event.</li>
<li>Our latest estimates suggest there could be two regular changes for F100 and six regular changes for F250 during the September 2025 rebalance.</li>
<li>After that, we expect multiple M&amp;A-related intra-review changes over the next few weeks.</li>
</ul>


In this insight, we take a look at the potential index changes for F100 and F250 in the run-up to the September 2025 index rebal event.
Our latest estimates suggest there could be two regular changes for F100 and six regular changes for F250 during the September 2025 rebalance.
After that, we expect multiple M&amp;A-related intra-review changes over the next few weeks.


Quiddity Leaderboard F100/F250 Sep25: ~10 Regular & Intra-Review Changes Likely in September

BioPharma Credit PLC Fund / Index Rebalance

<ul>
<li>In this insight, we take a look at the potential index changes for F100 and F250 in the run-up to the September 2025 index rebal event.</li>
<li>We see two M&amp;A-related intra-review changes for the F250 index prior to the September 2025 review and then at least four more before the end of the year.</li>
<li>Separately, our latest estimates suggest there could be one regular change for the F100 index and one regular change for F250 during the September 2025 rebalance.</li>
</ul>


In this insight, we take a look at the potential index changes for F100 and F250 in the run-up to the September 2025 index rebal event.
We see two M&amp;A-related intra-review changes for the F250 index prior to the September 2025 review and then at least four more before the end of the year.
Separately, our latest estimates suggest there could be one regular change for the F100 index and one regular change for F250 during the September 2025 rebalance.


Quiddity Leaderboard F100/F250 Sep25: High-Impact ADD Due to Rule Change + More Intra-Review Changes

United Kingdom

Spirent Communications plc provides electronic solutions for the technology industry, including businesses in the telecommunications and medical sectors. The Group specializes in telecommunications testing systems, including computer software and hardware systems, cable management systems, and transmitters. Spirent operates in the Americas, Europe and the Asia Pacific region.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Spirent Communications (SPT LN)

UK Competition Regulator Clears Keysight/Spirent Deal

UK's CMA clears Keysight-Spirent deal without Phase 2 investigation, boosting market confidence in acquisition completion by June 30, 2025.

Jesus Rodriguez Aguilar

Quiddity Leaderboard F100/F250 Dec25: Solid Lineup of High-Impact Intra-Review Changes

The Top 10 F250 potential ADDs from our Leaderboard could outperform the F250 index over the next few weeks due to intra-review index addition...

Janaghan Jeyakumar, CFA

Quiddity Leaderboard F100/F250 Dec25: Intra-Review Changes Galore; High-Impact Replacement Names

We expect at least five intra-review replacements in the F20 index prior to the December 2025 index review. There are three other deals that could...

Janaghan Jeyakumar, CFA

Quiddity Leaderboard F100/F250 Sep25: ~10 Regular & Intra-Review Changes Likely in September

F100/250 Sep25 index changes will be confirmed after market close today. Yesterday was the base date for final ranks. Please see discussion point...

Janaghan Jeyakumar, CFA

Quiddity Leaderboard F100/F250 Sep25: High-Impact ADD Due to Rule Change + More Intra-Review Changes

BioPharma Credit PLC Fund (BPCR LN) has been our top F250 potential ADD after a recent rule change. This could be a high-impact index addition that...

Janaghan Jeyakumar, CFA

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

UK Competition Regulator Clears Keysight/Spirent Deal

​UK's CMA clears Keysight-Spirent deal without Phase 2 investigation, boosting market confidence in acquisition completion by June 30, 2025.

Jesus Rodriguez Aguilar

Quiddity Leaderboard F100/F250 Dec25: Solid Lineup of High-Impact Intra-Review Changes

The Top 10 F250 potential ADDs from our Leaderboard could outperform the F250 index over the next few weeks due to intra-review index addition...

Janaghan Jeyakumar, CFA

Quiddity Leaderboard F100/F250 Dec25: Intra-Review Changes Galore; High-Impact Replacement Names

We expect at least five intra-review replacements in the F20 index prior to the December 2025 index review. There are three other deals that could...

Janaghan Jeyakumar, CFA

Quiddity Leaderboard F100/F250 Sep25: ~10 Regular & Intra-Review Changes Likely in September

F100/250 Sep25 index changes will be confirmed after market close today. Yesterday was the base date for final ranks. Please see discussion point...

Janaghan Jeyakumar, CFA

Quiddity Leaderboard F100/F250 Sep25: High-Impact ADD Due to Rule Change + More Intra-Review Changes

BioPharma Credit PLC Fund (BPCR LN) has been our top F250 potential ADD after a recent rule change. This could be a high-impact index addition that...

Janaghan Jeyakumar, CFA

UK's CMA clears Keysight-Spirent deal without Phase 2 investigation, boosting market confidence in acquisition completion by June 30, 2025.